In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

AFT Pharmaceuticals Limited Balance Sheet Statement - Assets

As of 31 Mar 2022, The total current assets of AFT Pharmaceuticals Limited (NZX:AFT) was around $77,542,000 which consisted of $7,940,000 of Cash, $33,500,000 of Inventory and $29,866,000 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in NZD

Current assets
Total assets

The latest balance sheet of AFT Pharmaceuticals Limited also showed $3,360,000 of Property Plant Equipment and no Good will. Also there were $15,988,000 of Intangible assets and $24,870,000 of Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $121,760,000.

AFT Pharmaceuticals Limited Balance Sheet Statement - Liabilities

AFT's latest annual results shows the balance sheet has $12,068,000 of Accounts Payable. Also there were $4,000,000 of Short/Long term debt, $33,200,000 of Long term debt, $4,328,000 of Other Current liabilities and $29,050,000 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
Current liabilities
Total liabilities

As per the 31 Mar 2022's annual report of AFT Pharmaceuticals Limited, the total liabilities were $65,016,000.

AFT Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of AFT Pharmaceuticals Limited showed the total stock holder equity was $56,744,000 which consisted of $80,770,000 of Common stocks, $-21,416,000 of Retained earnings and $-2,610,000 of Other stock holder equity.

AFT Balance Sheet Statement History

Following table shows the history of balance sheet for AFT Pharmaceuticals Limited (AFT).

31 Mar 202231 Mar 202131 Mar 202031 Mar 2019
Net Receivables29.87M29.23M22.63M16.28M
Total Current Assets77.54M67.9M55.34M51.26M
Property Plant Equipment3.36M3.79M4.03M357k
Good Will----
Intangible Assets15.99M15.59M15.46M2.91M
Other Assets24.87M17.86M12.23M6.03M
Deferred Long Term Asset Charges2.77M724k705k705k
Total Assets121.76M105.13M87.05M63.59M
Accounts Payable12.07M14.7M8.62M6.67M
Short/Long Term Debt4M5.16M2M41.75M
Other Current Liabilities4.33M4M7.39M6.63M
Long Term Debt33.2M33.2M41.2M-
Other Liabilities----
Total Current Liabilities29.05M32.1M25.1M58.5M
Total Liabilities65.02M68.54M69.8M58.5M
Common Stock80.77M80.36M57.06M57.06M
Retained Earnings-21.42M-41.26M-49.27M-61.01M
Treasury Stock-2.61M-2.51M-1.32M-1.33M
Other Stockholder Equity-2.61M-2.51M-1.32M-1.33M
Total Stockholder Equity56.74M36.59M6.46M-5.27M
Net Tangible Assets40.76M21M-9M-8.19M

AFT Pharmaceuticals Limited (NZX:AFT) Balance Sheet Statement FAQ

1. How much Cash AFT Pharmaceuticals Limited has on their balance sheet?

As of 31 Mar 2022, AFT Pharmaceuticals Limited (NZX:AFT) has $7,940,000 of Cash.

2. What's the long term debt of AFT Pharmaceuticals Limited?

As per the latest Balance sheet of AFT Pharmaceuticals Limited (NZX:AFT), it has $33,200,000 of Long term debt.

3. How much share holder equity does AFT Pharmaceuticals Limited has?

The AFT Pharmaceuticals Limited (NZX:AFT)'s balance sheet shows that it has $56,744,000 of Total stock holder equity.